Professional Associations

This page includes news coverage of medical associations and medical societies. Use these links to find focused news coverage from specific organizations: Cardiology Associations, Healthcare Associations, Radiology Associations.

New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS
Two separate studies at ACC.25 explored data from the EARLY TAVR trial. One analysis included stroke findings that surprised researchers.
Dapagliflozin improves outcomes for elderly TAVR patients with heart failure
The positive data were presented as part of a late-breaking clinical trial at ACC.25 in Chicago. One cardiologist on stage for the presentation said these findings will impact the way he manages certain TAVR patients.
American Heart Association program leads to substantial improvements in stroke care
Cardiologist Gregg Fonarow, MD, reviewed decades of data and discussed the long-term impact of the AHA's Get With The Guidelines-Stroke program.
Bringing state-of-the-art healthcare to Florida heart patients
Naples Comprehensive Health is building up what it hopes will be a nationally recognized cardiology program. Robert Cubeddu, MD, and Dee Dee Wang, MD, spoke with Cardiovascular Business about the journey so far.
Cardiologists make case against routine interventions for asymptomatic severe AS
Aortic valve replacement is likely inevitable for patients with asymptomatic severe aortic stenosis. Immediately performing TAVR or SAVR, however, may not always be the answer.

MRI system advances include helium-free MRI systems (left is Philips version of this system), and compressed sensing (right, GE's version of this technology), which can greatly reduce scan times. Both technologies were mentioned in an overview by Signet Research of new tech that will be at RSNA 2022.

VIDEO: Overview of MRI market and technology trends

Bhvita Jani, research manager, Signify Research, explains some key trends and technology advances in the magnetic resonance imaging (MRI) market leading into the Radiological Society of North America (RSNA) 2022 meeting.

Top MRI trends include helium-free systems, compressed sensing and AI

Signify Research outlines several key technologies and trends in MRI to look for at the Radiological Society of North America 2022 meeting.

Too much medical imaging, too little time to fix what’s broken?

A leading U.K. radiologist tells what he saw as this challenging scenario snowballed into being and what he believes must be done to make matters more manageable.

Final 2023 physician fee schedule out from CMS; early reactions register exasperation, resolve

CMS has finalized the Medicare Physician Fee Schedule (MPFS) for 2023, and its reimbursement reductions for radiology are less harsh than those proposed preliminarily in July.

Deepak Bhatt, MD, discusses the long-term, positive SYMPLICITY HTN-3 trial results presented at TCT 2022, and the future of renal denervation therapy to treat hypertension. #TCT

VIDEO: SYMPLICITY HTN-3 and the future of renal denervation

Deepak Bhatt, MD, MPH, details long-term outcomes from the SYMPLICITY HTN-3 trial, which show a lasting impact on patients with uncontrolled hypertension.

Late-breaking study examines IVL’s safety and effectiveness among real-life PAD patients

The new study, based on data from nearly 1,400 PAD patients who were treated with Shockwave Medical's IVL technology, was presented at VIVA22 in Las Vegas.

Ultrafast radiotherapy offers significant pain relief for patients with bone metastases

Experts involved in the new research suggested that their findings are in line with that of conventional palliative radiotherapy

Cardiologists, electrophysiologists ‘disappointed’ in final 2023 Medicare Physician Fee Schedule

The American College of Cardiology and Heart Rhythm Society issued a joint statement soon after CMS published its final rule for the 2023 Medicare Physician Fee Schedule. The groups warned that the final rule could threaten patient access to high-quality care.

Professional Associations

New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS

Dapagliflozin improves outcomes for elderly TAVR patients with heart failure

American Heart Association program leads to substantial improvements in stroke care

Bringing state-of-the-art healthcare to Florida heart patients

Cardiologists make case against routine interventions for asymptomatic severe AS